Dexamethasone inhibits the HSV-/ ganciclovir bystander effect in malignant glioma cells-0

<p><b>Copyright information:</b></p><p>Taken from "Dexamethasone inhibits the HSV-/ ganciclovir bystander effect in malignant glioma cells"</p><p>BMC Cancer 2005;5():32-32.</p><p>Published online 2 Apr 2005</p><p>PMCID:PMC1080125.</p><p>Copyright © 2005 Robe et al; licensee BioMed Central Ltd.</p>ed with ganciclovir (2 μM) for 5 days is shown in the presence (+) or absence (-) of dexamethasone (1 μM, DEX). Viability of LN18 cells mixed with 20 % LN18-TK cells and grown for 5 days with ganciclovir (10 μM) in the presence (+) or absence (-) of DEX. Viability of U87 cells mixed with 10 % U87-TK cells and grown for 5 days with ganciclovir (10 μM) in the presence (+) or absence (-) of DEX. For each condition, the viability in the absence of ganciclovir was set as 100 percents. (*: < 0.05, Student's t-test